TY  - JOUR 
AU  - Gómez-Reino Carnota, Juan Jesús
PY  - 2011
SN  - 1471-2474
UR  - http://hdl.handle.net/20.500.11940/5751
LA  - eng
TI  - Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study
DO  - 10.1186/1471-2474-12-153
T2  - BMC MUSCULOSKELETAL DISORDERS
VL  - 12
ER  -